Simultaneous transurethral resection of bladder tumor and benign prostatic hyperplasia in the treatment of non-muscle invasive bladder cancer with benign prostate hyperplasia for the aged patients
Deng Aihua
Liu Shiwei
Liu Lifang
Abstract：Objective: To evaluate the efficacy of simultaneous transurethral resection of bladder and prostate (TURBT+TURP) in the treatment of non-muscle invasive bladder cancer (NMIBC) with benign prostate hyperplasia (BPH) for the aged patients.Methods: The clinical data of 89 elderly patients with NMIBC and BPH were analyzed retrospectively.Forty-eight patients who underwent TURBT+TURP composed the combination group, and 41 patients who underwent TURP composed the control group.The surgery situation and prognosis were compared.Results: The operative time, blood loss and hospital stays in the combination group were obviously increased as compared with those in control group (P<0.01).After 1 year of operation, both the International Prostate Symptom Score (IPSS) and residual urine volume (PVR) value in the combination group were lower, and the maximal flow was higher than in the control group (P<0.01).After 2 years of operation, the recurrent rate was 2.1% and 17.1% respectively in the combination group and control group and the difference was significant (χ2=6.073, P<0.05).In the combination group, the incidence of urethral stricture was 2.1%, which was lower than that in the control group (17.1%) (χ2=6.073, P<0.01).Conclusions: Simultaneous TURBT and TURP can reduce the postoperative recurrence, relieve difficulty in voiding, decrease incidence of urethral stricture for aged patients with NMIBC and BPH.
Keywords：transurethral resection of bladdertransurethral resection of prostatenon-muscle invasive bladder cancerbenign prostate hyperplasia
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 158-161 )